Literature DB >> 15950749

Live cell imaging reveals distinct roles in cell cycle regulation for Nek2A and Nek2B.

Lynda Fletcher1, George J Cerniglia, Tim J Yen, Ruth J Muschel.   

Abstract

Two splice variants of Nek2 kinase, a member of the NIMA-related family, have been identified as Nek2A and Nek2B. Nek2A regulates centrosome disjunction, spindle formation checkpoint signaling, and faithful chromosome segregation. A specific role for Nek2B has not yet been identified. Here, we have examined the distinct roles of Nek2A and Nek2B using timelapse video microscopy to follow the fate of cells progressing through the cell cycle in the absence of either Nek2A or Nek2B. We show that the down-regulation of Nek2B leads to a mitotic delay in the majority of cells. Upon exiting mitosis, cells exhibit mitotic defects such as the formation of multinucleated cells. Such phenotypes are not observed in cells that exit mitosis in the absence of Nek2A. These observations suggest that Nek2B may be required for the execution of mitotic exit.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15950749     DOI: 10.1016/j.bbamcr.2005.01.007

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  17 in total

1.  Cancerous inhibitor of protein phosphatase 2A (CIP2A) protein is involved in centrosome separation through the regulation of NIMA (never in mitosis gene A)-related kinase 2 (NEK2) protein activity.

Authors:  Ae Lee Jeong; Sunyi Lee; Jeong Su Park; Sora Han; Chang-Young Jang; Jong-Seok Lim; Myung Sok Lee; Young Yang
Journal:  J Biol Chem       Date:  2013-11-08       Impact factor: 5.157

2.  Small molecule targeting the Hec1/Nek2 mitotic pathway suppresses tumor cell growth in culture and in animal.

Authors:  Guikai Wu; Xiao-Long Qiu; Longen Zhou; Jiewen Zhu; Richard Chamberlin; Johnson Lau; Phang-Lang Chen; Wen-Hwa Lee
Journal:  Cancer Res       Date:  2008-10-15       Impact factor: 12.701

3.  Identification of genetic variants contributing to cisplatin-induced cytotoxicity by use of a genomewide approach.

Authors:  R Stephanie Huang; Shiwei Duan; Sunita J Shukla; Emily O Kistner; Tyson A Clark; Tina X Chen; Anthony C Schweitzer; John E Blume; M Eileen Dolan
Journal:  Am J Hum Genet       Date:  2007-08-01       Impact factor: 11.025

4.  Synthesis and biological evaluation of a series of novel inhibitor of Nek2/Hec1 analogues.

Authors:  Xiao-Long Qiu; Guideng Li; Guikai Wu; Jiewen Zhu; Longen Zhou; Phang-Lang Chen; A Richard Chamberlin; Wen-Hwa Lee
Journal:  J Med Chem       Date:  2009-03-26       Impact factor: 7.446

5.  Identification by high-throughput screening of viridin analogs as biochemical and cell-based inhibitors of the cell cycle-regulated nek2 kinase.

Authors:  Daniel G Hayward; Yvette Newbatt; Lisa Pickard; Eilis Byrne; Guojie Mao; Samantha Burns; Navdeep K Sahota; Paul Workman; Ian Collins; Wynne Aherne; Andrew M Fry
Journal:  J Biomol Screen       Date:  2010-07-27

6.  G protein-coupled receptor kinase 2 (GRK2) is localized to centrosomes and mediates epidermal growth factor-promoted centrosomal separation.

Authors:  Christopher H So; Allison Michal; Konstantin E Komolov; Jiansong Luo; Jeffrey L Benovic
Journal:  Mol Biol Cell       Date:  2013-07-31       Impact factor: 4.138

7.  Insights into the conformational variability and regulation of human Nek2 kinase.

Authors:  Isaac Westwood; Donna-Marie Cheary; Joanne E Baxter; Mark W Richards; Rob L M van Montfort; Andrew M Fry; Richard Bayliss
Journal:  J Mol Biol       Date:  2008-12-24       Impact factor: 5.469

Review 8.  Cell cycle regulation by the NEK family of protein kinases.

Authors:  Andrew M Fry; Laura O'Regan; Sarah R Sabir; Richard Bayliss
Journal:  J Cell Sci       Date:  2012-11-06       Impact factor: 5.285

9.  Nek2-targeted ASO or siRNA pretreatment enhances anticancer drug sensitivity in triple‑negative breast cancer cells.

Authors:  Jaehyung Lee; Lauren Gollahon
Journal:  Int J Oncol       Date:  2013-01-22       Impact factor: 5.650

10.  Mitotic regulation by NIMA-related kinases.

Authors:  Laura O'regan; Joelle Blot; Andrew M Fry
Journal:  Cell Div       Date:  2007-08-29       Impact factor: 5.130

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.